- Novel Sulfonaminoquinoline Hepcidin Antagonists
-
The present invention relates to novel hepcidin antagonists, pharmaceutical compositions comprising them and the use thereof as medicaments for the use in the treatment of iron metabolism disorders, such as, in particular, iron deficiency diseases and anemias, in particular anemias in connection with chronic inflammatory diseases.
- -
-
-
- Synthesis of mono-and dialkylsubstituted 1,10-Phenanthrolines
-
Starting from o-anisidine, alkylated 8-hydroxyquinolines 2 and 8-aminoquinolines 3 were obtained. From the latter, dialkylsubstituted 1,10-phenanthrolines 5 have been prepared in good yields. Reaction of unsubstituted 8-aminoquinoline under the same conditions, yielded monoalkylated 1,10-phenanthrolines 4.
- Belser, Peter,Bernhard, Stefan,Guerig, Urs
-
p. 2937 - 2944
(2007/10/03)
-